Lipum AB Valuation

LIPUM Stock  SEK 14.30  1.90  11.73%   
At this time, the firm appears to be overvalued. Lipum AB secures a last-minute Real Value of kr12.03 per share. The latest price of the firm is kr14.3. Our model forecasts the value of Lipum AB from analyzing the firm fundamentals such as Shares Outstanding of 7.65 M, return on equity of -1.81, and Operating Margin of 117.68 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
14.30
Please note that Lipum AB's price fluctuation is somewhat reliable at this time. Calculation of the real value of Lipum AB is based on 3 months time horizon. Increasing Lipum AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lipum stock is determined by what a typical buyer is willing to pay for full or partial control of Lipum AB. Since Lipum AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lipum Stock. However, Lipum AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  14.3 Real  12.03 Hype  14.3 Naive  14.49
The intrinsic value of Lipum AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lipum AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
12.03
Real Value
15.70
Upside
Estimating the potential upside or downside of Lipum AB helps investors to forecast how Lipum stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lipum AB more accurately as focusing exclusively on Lipum AB's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
14.2316.2118.19
Details
Hype
Prediction
LowEstimatedHigh
10.6314.3017.97
Details
Naive
Forecast
LowNext ValueHigh
10.8214.4918.16
Details

Lipum AB Total Value Analysis

Lipum AB is now projected to have takeover price of 98.1 M with market capitalization of 104.07 M, debt of 1.57 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lipum AB fundamentals before making investing decisions based on enterprise value of the company

Lipum AB Asset Utilization

One of the ways to look at asset utilization of Lipum is to check how much profit was generated for every dollar of assets it reports. Lipum AB secures a negative usage of assets of -0.91 %, losing kr0.009118 for each kronor of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each kronor of assets it secures. Strictly speaking, asset utilization of Lipum AB shows how discouraging it operates for each kronor spent on its assets.

Lipum AB Ownership Allocation

The market capitalization of Lipum AB is kr104.07 Million. Lipum AB secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.67 % of Lipum AB outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Lipum AB Profitability Analysis

Net Loss for the year was (52.26 M) with loss before overhead, payroll, taxes, and interest of (48.69 M).

About Lipum AB Valuation

The stock valuation mechanism determines Lipum AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lipum AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lipum AB. We calculate exposure to Lipum AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lipum AB's related companies.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden.

8 Steps to conduct Lipum AB's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lipum AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lipum AB's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Lipum AB's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Lipum AB's revenue streams: Identify Lipum AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Lipum AB's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Lipum AB's growth potential: Evaluate Lipum AB's management, business model, and growth potential.
  • Determine Lipum AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lipum AB's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for Lipum Stock Analysis

When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.